Sign in
RGMP Stock Price, Chart, Stats & News
Regnum Corp.
Save
Regnum Corp. (RGMP) does not currently pay a dividend.
2,295
Market cap
–
Current P/E
–
Forward P/E
RGMP chart
1M
3M
1Y
5Y
Loading chart...
About
Communication Services
Sector
Entertainment
Industry
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody CC chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York.
Similar securities
Based on sector and market capitalization
Report issue